Results 131 to 140 of about 34,514 (296)

Impact of the implantable cardioverter-defibrillator on rehospitalizations

open access: yes, 2017
Patients who survive out-of-hospital ventricular tachycardia or ventricular fibrillation are at risk of sudden cardiac death and often return to hospital after initial discharge.
Fromer, M.   +4 more
core  

Sexual concerns and educational needs after an implantable cardioverter defibrillator

open access: yes, 2005
Click on the DOI link to access the article (may not be free).Patients with an implantable cardioverter defibrillator (ICD) describe anxiety, fears, and other psychosocial issues, although sexual concerns are not well understood.peer ...
Steinke, Elaine E.   +3 more
core   +1 more source

Utilization and Prognosis of Cardiac Device Implantation in AL Versus ATTR Amyloidosis

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Cardiac amyloidosis can cause congestive heart failure, arrhythmias, and heart blocks, which frequently require cardiac device implantation (CDI). However, the differences between light chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis CDI requirements are unknown. Methods A retrospective analysis was conducted using the
Bilal Hussain   +7 more
wiley   +1 more source

Early Mobilization After Pacemaker Implantation

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The increasing use of cardiac implantable electronic devices (CIED) is leading to a rise in procedure‐related complications. Objective This trial aimed to assess the safety and feasibility of early mobilization and the possibility of same‐day discharge following permanent pacemaker implantation.
Jiří Šmíd   +3 more
wiley   +1 more source

Inappropriate implantable cardioverter-defibrillator shocks due to temporary epicardial pacing

open access: yes, 2010
Oversensing of external electrical signals can cause inappropriate therapy in cardiac rhythm management devices. In this report, a patient with an implantable cardioverter-defibrillator (ICD) is presented, who received inappropriate shocks due to ...
van Opstal, Jurren   +5 more
core   +1 more source

Incidence and Determinants of Implantable Cardioverter‐Defibrillator Therapy With Loss of and Impaired Consciousness

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Implantable cardioverter‐defibrillators (ICDs) are important in the prevention of sudden cardiac death. However, some appropriate ICD therapies may be considered unnecessary, delivered when patients do not experience symptoms of hemodynamic instability such as loss of consciousness.
Alwin B. P. Noordman   +5 more
wiley   +1 more source

A Tale of Two “Unexpected” Asystoles

open access: yesJournal of Cardiovascular Development and Disease
We report two cases of prolonged “unexpected” asystoles in patients with a wearable cardioverter-defibrillator (WCD) and a subcutaneous implantable cardioverter-defibrillator (ICD), respectively, which were promptly recognized and successfully managed ...
Giacomo Mugnai   +3 more
doaj   +1 more source

Infections after high-voltage cardiac implantable electronic device replacements

open access: yesHeart Rhythm O2
Background: Device infection is the most worrisome complication after replacement of cardiac implantable electronic devices, with the utmost risk among patients with replacement of a high-voltage device.
Rasmus Langhoff, BM   +7 more
doaj   +1 more source

Implantable cardioverter defibrillator pocket infection caused by Klebsiella pneumonia

open access: yes, 2012
Like any other foreign bodies, implanted cardiac devices can become infected. Staphylococcus aureus and coagulase-negative Staphilococci are the most common causes of infections of pacemaker and defibrillator systems.
Soydinc, S.   +9 more
core   +1 more source

QT Interval Evaluation in Right Ventricular Pacing: Validation of a Novel Formula

open access: yesPacing and Clinical Electrophysiology, EarlyView.
Abstract Background QT interval measurement in the presence of right ventricular pacing (RVP) represents a clinical challenge. We therefore aimed to derive and validate a formula for QT estimation during RVP in a large cohort of pacemaker patients. Methods and Results We prospectively enrolled 100 patients in a derivation cohort and 487 in a validation
Amr Abdin   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy